1. Home
  2. CTKB vs MYI Comparison

CTKB vs MYI Comparison

Compare CTKB & MYI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CTKB
  • MYI
  • Stock Information
  • Founded
  • CTKB 1990
  • MYI 1992
  • Country
  • CTKB United States
  • MYI United States
  • Employees
  • CTKB N/A
  • MYI N/A
  • Industry
  • CTKB Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • MYI Investment Bankers/Brokers/Service
  • Sector
  • CTKB Health Care
  • MYI Finance
  • Exchange
  • CTKB Nasdaq
  • MYI Nasdaq
  • Market Cap
  • CTKB 697.0M
  • MYI 766.4M
  • IPO Year
  • CTKB 2021
  • MYI N/A
  • Fundamental
  • Price
  • CTKB $5.30
  • MYI $11.65
  • Analyst Decision
  • CTKB Buy
  • MYI
  • Analyst Count
  • CTKB 4
  • MYI 0
  • Target Price
  • CTKB $8.50
  • MYI N/A
  • AVG Volume (30 Days)
  • CTKB 517.4K
  • MYI 256.7K
  • Earning Date
  • CTKB 08-06-2024
  • MYI 01-01-0001
  • Dividend Yield
  • CTKB N/A
  • MYI 4.81%
  • EPS Growth
  • CTKB N/A
  • MYI N/A
  • EPS
  • CTKB N/A
  • MYI N/A
  • Revenue
  • CTKB $197,711,000.00
  • MYI N/A
  • Revenue This Year
  • CTKB $8.13
  • MYI N/A
  • Revenue Next Year
  • CTKB $15.93
  • MYI N/A
  • P/E Ratio
  • CTKB N/A
  • MYI N/A
  • Revenue Growth
  • CTKB 12.60
  • MYI N/A
  • 52 Week Low
  • CTKB $3.80
  • MYI $9.32
  • 52 Week High
  • CTKB $9.87
  • MYI $11.70
  • Technical
  • Relative Strength Index (RSI)
  • CTKB 43.03
  • MYI 67.93
  • Support Level
  • CTKB $5.20
  • MYI $11.58
  • Resistance Level
  • CTKB $5.50
  • MYI $11.71
  • Average True Range (ATR)
  • CTKB 0.23
  • MYI 0.06
  • MACD
  • CTKB 0.00
  • MYI 0.01
  • Stochastic Oscillator
  • CTKB 16.95
  • MYI 77.78

About CTKB Cytek Biosciences Inc.

Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of cell analysis tools by leveraging novel technical approaches. Its core instruments, the Cytek Aurora and Northern Lights systems, are the first full-spectrum flow cytometers able to deliver high-resolution, high-content, and high-sensitivity cell analysis by utilizing the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its FSP platform addresses the inherent limitations of other technologies by providing a higher density of information with greater sensitivity, more flexibility, and increased efficiency, all at a lower cost for performance. Geographically, the company generates a majority of its revenue from the United States.

About MYI Blackrock MuniYield Quality Fund III Inc

BLACKROCK MUNIYIELD QUALITY FUND III, INC. is a diversified, closed-ended investment management company. Its investment objective is to provide shareholders with a high level of current income exempt from U.S. federal income taxes as is consistent with its investment policies and prudent investment management. The company invests in various sectors such as Transportation; Utilities; Health; Education; Tobacco and others.

Share on Social Networks: